![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 7
2019
Doppelhammer, Maximilian; Fraccaroli, Alessia; Prevalsek, Dusan; Buecklein, Veit; Haebe, Sarah; Schulz, Christoph; Hubmann, Max; Hausmann, Andreas; Claus, Rainer; Rank, Andreas; Schmid, Christoph und Tischer, Johanna
(2019):
Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioninga matched pair analysis.
In: Annals of Hematology, Bd. 98, Nr. 3: S. 753-762
2018
Schranz, Katrin; Hubmann, Max; Harin, Egor; Vosberg, Sebastian; Herold, Tobias; Metzeler, Klaus H.; Rothenberg-Thurley, Maja; Janke, Hanna; Bräundl, Kathrin; Ksienzyk, Bianka; Batcha, Aarif M. N.; Schaaf, Sebastian; Schneider, Stephanie; Bohlander, Stefan K.; Görlich, Dennis; Berdel, Wolfgang E.; Wörmann, Bernhard J.; Braess, Jan; Krebs, Stefan; Hiddemann, Wolfgang; Mansmann, Ulrich; Spiekermann, Karsten und Greif, Philipp A.
(2018):
Clonal heterogeneity of FLT3-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia.
In: Oncotarget, Bd. 9, Nr. 53: S. 30128-30145
[PDF, 2MB]
Rothenberg-Thurley, Maja; Amler, Susanne; Goerlich, Dennis; Köhnke, Thomas; Konstandin, Nikola P.; Schneider, Stephanie; Sauerland, Maria C.; Herold, Tobias; Hubmann, Max; Ksienzyk, Bianka; Zellmeier, Evelyn; Bohlander, Stefan K.; Subklewe, Marion; Faldum, Andreas; Hiddemann, Wolfgang; Braess, Jan; Spiekermann, Karsten und Metzeler, Klaus H.
(2018):
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
In: Leukemia, Bd. 32, Nr. 7: S. 1598-1608
Fraccaroli, Alessia; Prevalsek, Dusan; Fritsch, Susanne; Haebe, Sarah; Buecklein, Veit; Schulz, Christoph; Hubmann, Max; Stemmler, Hans-Joachim; Ledderose, Georg; Hausmann, Andreas; Schmid, Christoph und Tischer, Johanna
(2018):
Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS.
In: American Journal of Hematology, Bd. 93, Nr. 12: S. 1524-1531
2016
Hubmann, Max; Fritsch, Susanne; Zoellner, Anna-Katharina; Prevalsek, Dusan; Engel, Nicole; Bücklein, Veit; Mumm, Friederike; Schulz, Christoph; Stemmler, Hans Joachim; Jäger, Gundula; Ledderose, Georg; Kolb, Hans Jochem; Hausmann, Andreas; Hiddemann, Wolfgang; Moosmann, Andreas und Tischer, Johanna
(2016):
Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
In: Journal of Clinical Virology, Bd. 82: S. 33-40
Zoellner, Anna-Katharina; Fritsch, Susanne; Prevalsek, Dusan; Köhnke, Thomas; Hubmann, Max; Lippl, Stephanie; Kruger, Stephan; Hellmuth, Johannes; Mumm, Friederike; Ledderose, Georg; Barlow, Sophie; Subklewe, Marion; Spiekermann, Karsten; Hiddemann, Wolfgang; Albert, Michael H.; Schmid, Christoph; Hausmann, Andreas und Tischer, Johanna
(2016):
T-Cell-Replete HLA-Haploidentical Transplantation Using Post-Transplantation High-Dose Cyclophosphamide in High Risk and Advanced ALL: Feasibility and Early Outcome.
In: Biology of Blood and Marrow Transplantation, Bd. 22, Nr. 3:
S364-S364
2014
Hubmann, Max; Köhnke, Thomas; Hoster, Eva; Schneider, Stephanie; Dufour, Annika; Zellmeier, Evelyn; Fiegl, Michael; Braess, Jan; Bohlander, Stefan K.; Subklewe, Marion; Sauerland, Maria-Cristina; Berdel, Wolfgang E.; Büchner, Thomas; Woermann, Bernhard; Hiddemann, Wolfgang und Spiekermann, Karsten
(2014):
Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.
In: Haematologica, Bd. 99, Nr. 8: S. 1317-1325
[PDF, 838kB]